Newsletter Subject

These High-Flying Growth Stocks Are Now Value Trades

From

jeffclarktrader.com

Email Address

service@exct.jeffclarktrader.com

Sent On

Fri, May 7, 2021 11:31 AM

Email Preheader Text

This sector might surprise investors. These High-Flying Growth Stocks Are Now Value Trades By Jeff C

This sector might surprise investors. [Jeff Clark's Market Minute]( These High-Flying Growth Stocks Are Now Value Trades By Jeff Clark, editor, Market Minute The biotech sector is one of the only “value” plays in the market right now. It’s crazy, I know. Biotech stocks are super volatile. They’re normally seen as high risk/high reward. It’s certainly not a sector that most folks should consider buying with their “safe” money. But hey, it’s 2021. This is the year of crazy… Recommended Link [CNBC: “Market Bubble Is Here” (What To Do Next)]( [image]( The rich are getting nervous… According to CNBC, “The wealthy are investing like a market bubble is here” and “are making portfolio changes.” But what changes? Former Wall Street insider and hedge fund manager Teeka Tiwari uncovered [a growing trend among America’s 1%]( Quietly and behind the scenes, some of the smartest, wealthiest investors in the country (including Warren Buffett) are making an important shift with their money. They’re not rushing into cryptocurrencies… gold… tech stocks… or real estate. And they’re not hiding in cash either. [Find out what the rich are doing with their fortunes HERE]( -- Investors have been throwing money into Special Purpose Acquisition Companies (SPAC), Non-Fungible Tokens (NFT), cryptocurrencies with no function, low-quality bonds that offer little return, and regular stocks that are trading at historically ridiculous valuations. And, for some reason, they’ve been selling off the biotech stocks. The S&P 500 is up about 11% so far in 2021. The S&P Biotech ETF (XBI) is down 11%. This lagging performance has pushed the biotech sector down to the lowest value – relative to the S&P 500 – we’ve seen in over a year. Take a look at this ratio chart comparing XBI to the S&P 500… [(Click here to expand image)]( When this chart is moving higher, biotech stocks are outperforming the broad stock market. When the chart is falling – XBI is lagging the market. The biotech sector peaked in early February. And, it's basically been a straight shot lower since then. We’re at the point now, though, that the high-flying biotech stocks are looking like value stocks. Free Trading Resources Have you checked out Jeff's free trading resources on his website? It contains a selection of special reports, training videos, and a full trading glossary to help kickstart your trading career – at zero cost to you. Just [click here]( to check it out. Consider United Therapeutics (UTHR), for example. UTHR is a $9 billion company. It’s a top-five holding in XBI. And, after pulling back about 10% over the past month, UTHR trades for about 14 times this year’s earnings estimates. That’s quite a bargain compared to the 23 times forward earnings investors are willing to pay for the S&P 500. [This one stock could be the game changer you’re looking for]( Now, I’m not suggesting that folks just blindly throw money into the biotech sector because it’s cheap relative to the broad stock market. But, I am saying that if you’re looking for value in a market environment that's squeezed just about every drop of value out of it, then maybe you have to look outside of the ordinary. After all, we found value in the gold sector [about a month ago](. That seems to be working out pretty well so far. So, maybe it’s time to start looking for value in the biotech sector. Best regards and good trading, Jeff Clark P.S. For the last few months, my colleague Eoin Treacy has been writing the Saturday Market Minute. And, he’s shared plenty of great ideas on [copper]( [bitcoin]( and even [alternative energy sources](. But recently, Eoin shared one of his market analysis videos with me. He regularly films and shares these videos with institutional-grade investors. I asked if he’d be willing to share them with you… And he accepted. So on each Friday going forward, you can expect a new video from Eoin Treacy, sharing his newest trading ideas and off-the-cuff market insights. Check it out below, and let us know what you think of it [right here](mailto:feedback@jeffclarktrader.com). Eoin’s Insights Hey Market Minute readers, Eoin Treacy here with some market commentary. Today, I’ll be discussing some companies in the Solactive Stay At Home US Index, inflation, and the trades to watch for post-pandemic. Just click below to watch… All the best, Eoin Treacy Reader Mailbag What are some other sectors of the market with value, but are currently being overlooked by the broad market? Let us know your thoughts – and any questions you have – at feedback@jeffclarktrader.com. In Case You Missed It… [Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)]( “Hi, I’m Jeff Brown… I’m about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk’s next big project… What happens next will shock you…” [Click here to see what happened.]( [image]( Get Instant Access Click to read these free reports and automatically sign up for daily research. [image]( [An Insider’s Guide to Making a Fortune from Small Tech Stocks]( [image]( [The Gold Investor's Guide]( [image]( [How to Earn Free Bitcoin]( [Jeff Clark's Market Minute]( Jeff Clark Trader 55 NE 5th Avenue, Delray Beach, FL 33483 [www.jeffclarktrader.com]( To ensure our emails continue reaching your inbox, please [add our email address]( to your address book. This editorial email containing advertisements was sent to {EMAIL} because you subscribed to this service. To stop receiving these emails, click [here](. Jeff Clark Trader welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice. To contact Customer Service, call toll free Domestic/International: 1-800-752-0820, Mon–Fri, 9am–7pm ET, or email us [here](mailto:contactus@jeffclarktrader.com). © 2021 Omnia Research, LLC. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Omnia Research, LLC. [Privacy Policy]( | [Terms of Use](

Marketing emails from jeffclarktrader.com

View More
Sent On

06/12/2024

Sent On

04/12/2024

Sent On

03/12/2024

Sent On

29/11/2024

Sent On

27/11/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.